Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- ELISA [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab170892 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Daclizumab (anti-IL2RA)
- Antibody type
- Recombinant
- Description
- Daclizumab (anti-IL2RA) is a humanized, monoclonal antibody that blocks CD25 (_-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (anti-IL2RA) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (anti-IL2RA) can be used for multiple sclerosis research.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
- Reactivity
- Human, Mouse, Rat
- Conjugate
- Unconjugated
- Vial size
- 100_g,10mg,1mg,5mg
- Concentration
- Lot by Lot
- Storage
- Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Daclizumab (anti-IL2RA) (Ab170892) - ELISA Immobilized TARGET at 2 μg/mL can bind Daclizumab (anti-IL2RA) (Ab170892) with the EC₅₀ of 31.47 ng/mL.
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Daclizumab (anti-IL2RA) (Ab170892) - Flow Cytometry Flow Cytometry analysis of PHA-stimulated (3 days) human peripheral blood mononuclear lymphocytes labelling IL2RA (red) with Daclizumab (anti-IL2RA) (Ab170892). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
